Patients with HER2-positive breast cancer or triple-negative (HER2− ER− PR−) breast cancer (TNBC) have a higher risk of brain metastasis compared with those with the luminal subtype (ER+ or PR+) of breast cancer. The gene discussed is ERBB2; the disease is breast cancer.